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Atrial fibrillation (AF) affects over 1.4 million people in the UK, resulting in a five-fold 
increased stroke risk and a three to four times greater risk of severe, disabling stroke. AF, a 
chronic disease, requires monitoring, medication and lifestyle measures. A self-management 
approach supported by mobile health (mHealth) may empower AF self-care.   
Aims 
To assess the need to develop new mHealth self-management interventions for those with 
AF. This review aimed to identify commercially available AF self-management apps, analyse 
and synthesise a) characteristics b) functions c) privacy/security d) incorporated behaviour 
change techniques, and e) quality and usability.      
Methods 
We searched app stores for “atrial fibrillation” and “anticoagulation”, and included apps 
focused on AF self-management in the review. We examined app functions, privacy 
statements against best practice recommendations, the inclusion of behaviour change 
techniques using the App Behaviour Change Scale, and app quality/usability using the 
Mobile App Rating Scale. 
Results 
From an initial search of 555 apps, five apps were included in the review. Common functions 
were educational content, medication trackers and communication with healthcare 
professionals. Apps contained limited behaviour change techniques, lacked intuitive 
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functions and were difficult to use. Privacy policies were difficult to read. App quality rated 
from poor to acceptable and no app had been evaluated in a clinical trial. 
 Conclusion 
The review reports a lack of commercially available AF self-management apps of sufficient 
standard for use in healthcare settings. This highlights the need for clinically validated 
mHealth interventions incorporating evidence-based behaviour change techniques to 
support AF self-management.      
Key words 
Atrial fibrillation, mHealth, medication adherence, self-management, anticoagulation, 




Atrial fibrillation (AF), the most prevalent clinically significant arrhythmia,1 increases 
the risk of a thromboembolic event five-fold.2, 3 Estimates suggest that in the UK over 
1 million adults will be diagnosed with AF by 20404 and at least 4.7% of individuals 
with AF will have an ischaemic stroke.5 Of greatest concern, AF-related strokes are 
more likely to be fatal or severely disabling compared to stroke of other aetiology.6 
Consequently, the financial and social burden of AF-related stroke is much greater. 
AF has been estimated to cost the National Health Service (NHS) in the UK £770 
million over a five-year period7 and this is likely to increase as the prevalence of AF 
rises.1, 8 Those with symptomatic AF, who suffer from breathlessness, palpitations 
and/or fatigue may experience reduced quality of life, poor functional status1 and 
increased risk of hospital admission.7 To mitigate health costs and improve patient 
outcomes, the National Institute for Health and Care Excellence (2014) recommends 
that AF treatment should emphasise the prevention of thromboembolic complications 
through increased stroke awareness and oral anticoagulation (OAC), concurrent with 
heart rate control.9 
Adherence to medication is only part of the long-term management of AF. Globally, 
AF guidelines advocate a self-management approach. Chronic disease self-
management generally encompasses a range of activities from tracking symptoms to 
increasing physical activity, adhering to a special diet and supporting mental health 
in an effort to engage patients to take an active role in their own care.10 Patient self-
efficacy is a key enabler of self-management and should be promoted through 
education.11, 12  
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Mobile health (mHealth) apps are an innovative potential solution to support self-
management by monitoring behaviour, symptoms, medication and physiological 
measurements such as heart rate.13, 14 mHealth apps, used independently or in 
conjunction with healthcare professional guidance, have been developed with the 
aim of improving clinical outcomes in cardiovascular health, diabetes and chronic 
lung conditions.15 Due to their ability to provide updated, clinically relevant and 
targeted information to individuals, apps have the potential to be successful in a 
range of settings by offering far-reaching educational and tracking support.16 Apps 
have the capacity to integrate behaviour change techniques (BCTs) within their 
software. BCTs are evidence based replicable components incorporated into health 
interventions to change or regulate behaviour patterns17 and their presence or 
absence is often predictive of an interventions success.  
Despite their potential, mHealth apps often lack the necessary components of self-
management required to support patients with long term conditions, such as 
customised medical advice.18 Complications arise when elements within an app 
transition it from a support tool to a medical device. Regulation as a medical device 
ensures apps are safe and of high quality19 but once registered, they become less 
accessible to the general population. Most apps therefore, are not regulated and 
these widely available apps are what many will choose to support health behaviour 
change. 
The lack of theoretical underpinning to inform and guide behaviour change, such as 
increasing medication adherence or physical activity levels, raises questions about 
app benefits for users.20 Personal data privacy is a particular issue, with extreme 
variations in data protection principles identified in apps registered with the NHS 
Health Apps Library, a database designed to help the public find trusted health 
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apps.21, 22  At present, poor regulation and easy accessibility to poorly evidenced 
apps pose significant legal and ethical implications.15, 23 This could negatively 
influence patient and public perception of apps and act as a barrier to uptake of the 
technology among target populations. It is important that we understand what 
elements of mHealth apps are likely to increase adoption and influence behaviour, 
and how this could improve medication adherence in people living with AF. 
Systematic reviews with content analyses have examined quality, functionality and 
underpinning behaviour change theory of mHealth apps used for hypertension,20, 24 
pain,25 smoking cessation,26 mental health,27 and diabetes28 but not AF. Therefore, 
this study aims to identify and evaluate commercially available AF self-management 
apps and explore a) app characteristics, b) functions, c) privacy and security, d) 
underpinning theoretical behaviour change, and e) quality and usability.  
Methods 
This study used publicly available data to perform a content analysis and review of 
apps supporting AF self-management. Where appropriate, we report results using 
the Preferred Reporting Items for Systematic Reviews and Meta-Analyses.29 
In September 2019, we undertook an electronic search of two major mobile 
application stores, Google Play (Android operating system) and Apple App Store 
(iPhone operating system). Data were collected from 2-8 September 2019. We 
separately searched the terms “atrial fibrillation” and “anticoagulation” in both stores 
with no restrictions on subcategories or number of applications. We also included the 




Inclusion and exclusion criteria 
Two investigators (AP and CLH) pre-screened apps for suitability based on the app 
descriptions and screenshots provided in the app stores. We included apps that 
were: 
 Written in English and where atrial fibrillation was directly included in the key 
words or images accompanying the app description  
 Intended for those with a diagnosis of AF 
 Alluded to self-management capabilities in their description e.g. education, 
tracking, physical/mental health, symptom control and anticoagulation 
medication 
We included both paid and free apps.  
We excluded apps if: 
 The app software did not function when downloaded  
 They required identification, e.g. patient number/prescription access    
 They were designed for use in one hospital or as part of a specific study  
 They did not mention AF  
 They had no self-management function, i.e. were intended as a self-diagnosis 
tool; focused on arrhythmia detection; or solely focused on evaluating stroke 
risk as a consequence of AF 
Apps that appeared in both the Apple App and Google Play stores were 
independently analysed to account for differences in functionality across operating 
systems. Following initial identification, one investigator (AP) downloaded apps onto 
an Apple iPad Air (operational system iOS 12.4.1) and Samsung S7 (operational 
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system android 8.0) and subsequently re-evaluated against the same inclusion and 
exclusion criteria.  
Data collection 
For apps that met the selection criteria, we assessed a) app characteristics, b) 
functions, c) privacy and security, d) underpinning theoretical behaviour change, and 
e) quality and usability. 
App characteristics 
We recorded app name, developer, version date, operational system, price, rating, 
number of downloads and healthcare professional and/or patient involvement during 
the development of apps. We based this on app store descriptions or “about” 
sections within app and noted whether apps had been, or were undergoing, clinical 
trial.  
App functions 
One researcher (AP) used the apps concurrently for one week before classifying the 
presence and frequencies of app functions, as identified in previous medication 
adherence mHealth studies, under ‘Educational Information’, ‘Self-Monitoring’, ‘App 
User Interaction’, and ‘Patient Medical and Support Network’.16, 20, 24, 30, 31 
Privacy and security 
We assessed app privacy and security against Online Trust Alliance Best Practices: 
Privacy recommendations.32 Two independent reviewers (AP and SK) assessed 
apps against four elements: basic notice/disclosure, key compliance policies, 
protected privacy and protected sharing criteria, and miscellaneous privacy 
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elements. We analysed readability of privacy policies utilising the Flesch-Kincaid 
Reading Ease Score.33 
Incorporated behaviour change techniques 
Three reviewers (AP, CH, SK) completed online behaviour change taxonomy 
training34 before assessing each app against the behaviour change technique (BCT) 
theoretical framework17 for the 12 BCTs previously identified in apps targeting 
medication adherence.35 Concurrently, BCTs were reviewed against a recently 
developed App Behaviour Change Scale (ABACUS).36 Any discrepancies were 
resolved by discussion until consensus was agreed. 
Quality and usability  
The Mobile Application Rating Scale (MARS)37 was utilised by six reviewers with 
backgrounds in nursing, digital health and behavioural change theory research (AP, 
CLH, SM, SS, SK, MZ) to assess overall app quality by evaluating four dimensions: 
engagement, functionality, aesthetic and information quality. Reviewers scored each 
element on a 5-point scale (1=inadequate to 5=excellent), with mean scores 
calculated for each dimension and an overall mean quality score calculated from the 
four objective dimensions. An additional subjective quality score provided a measure 
of whether reviewers believed those with AF would use the app, by considering apps 
from an end user perspective.   
Statistical analysis  
We analysed data using SPSSv26. We reported descriptive statistics for app 
functions, privacy and security best practice elements, and behaviour change 
techniques identified. Each subscale within the MARS was analysed using the mean 
value as per the original study methodology,37 with interrater reliability analysed 
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using a two-way mixed intraclass correlation coefficient (ICC). The relationships 
among the MARS subscales were analysed by Spearman correlation.   
Results  
We identified 555 apps (487 Android OS and 68 iPhone OS) and screened these 
against the inclusion/exclusion criteria. We downloaded 32 apps for in-depth 
screening and included five apps in the comprehensive analysis (Figure 1). 
App characteristics 
Three apps were available through Android OS. Of the two apps available from 
Apple, one was a duplicate from the Google Play store but was assessed for 
functionality across both operating platforms. For the purposes of this review, these 
were classed as two separate apps (Table 1). All apps included in the final analysis 
were free of charge. 
App functions   
The most common functions were AF related educational content, symptom diaries 
and healthcare professional communication (Table 2). Four of the five apps 
contained self-monitoring functions for physiological measurements that relied on 
manual data entry. No app offered recording capabilities via wearables. Journals 
were found to be exportable in two apps via emailed PDF documents or in-app 
printable versions. Networking was available in 4/5 of apps, allowing users to 
communicate with healthcare professionals (4/5 apps), community networks (1/5 
apps) and friends/family (1/5apps).   
Privacy and security 
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Privacy policies were available in 4/5 apps prior to download (Table 3). All privacy 
policies were available in English and stated compliance with General Data 
Protection Regulation. Flesch Kincaid Reading scores ranged from 25 to 48 (<50 
college level; <30 graduate level). The privacy policies of four apps explicitly stated 
the collection, but not distribution, of personally identifiable information. Four apps 
reported sharing non-identifiable data via cookies with third parties. Apps secured 
data by encryption.   
Incorporated behaviour change techniques 
We identified the presence of seven BCTs from a possible 12,35 with a range of one 
to six per app. As highlighted by the ABACUS,36 no app embedded goal setting 
capabilities or included instruction, demonstration and rehearsal for specific 
behaviours. There was consensus from both scales that knowledge, monitoring and 
feedback were the most commonly utilised BCTs (Table 4).  
Quality and usability  
The MARS score was used to rate quality of the apps. Across all apps the mean 
Overall Quality Total score was 3.5 (SD 0.65), indicating acceptable quality37 (Table 
5). Mean Subjectivity Quality (not included in the MARS calculated overall quality 
total) was 2.7 (SD 0.84). This gave apps a rating of poor to acceptable. No app 
received an overall average quality or subjectivity score ≥4, meaning that none of the 
apps achieved an overall good or excellent rating.  
Strong positive correlations were found between Engagement and Aesthetics (rs = 
0.941, p= .005) and Subjectivity and Aesthetics (rs = 0.941, p= .005). Positive 
relationships were also found within Functionality and Engagement (rs = 0.824, p= 
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.044) and Information Quality and Engagement (rs = 0.824, p= .044). No relationship 
could be determined between Functionality and Aesthetics (rs = 0.765, p= .077) and 
Information Quality and Aesthetics (rs = 0.765, p= .077). Interrater reliability across all 
MARS subscales and all included apps was excellent (2-way mixed ICC= 0.82).38 
Internal consistencies of the MARS subscales engagement, functionality and 
information quality showed moderate to good interrater reliability (2-way mixed ICC= 
0.66, 0.76, 0.65 respectively), with the aesthetic quality showing very poor reliability 
(2-way mixed ICC= 0.26).  
Discussion  
This review provides a detailed analysis of freely available mHealth apps aimed at 
encouraging AF self-management. We identified four different apps, one of which 
was duplicated on Android and Apple platforms and performed identically across 
both. With a total of five apps to analyse, the most influential finding from this review 
is the lack of available AF self-management apps, a contrast to, for example, the 
plethora of hypertension apps (n=186).20 
Of the five apps analysed, the most common functions were AF related educational 
content, symptom diaries and healthcare professional communication. Privacy 
policies were available for four out of five apps prior to download and one after 
download, but assessment of readability indicated potential issues with 
understanding the meaning and intent of the information for those without college 
level education. Most apps included some behaviour change techniques, for 
example self-monitoring and information about health consequences, but none 
contained goal setting, a common and often effective behaviour change technique. 
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The quality of apps ranged from poor to acceptable, as assessed using MARS.37 
This study reported mean values in line with the original study methodology in order 
to ensure that the review will be comparable to previous health app content analysis 
studies.39, 40, 41, 42  
Educational content is an important element of an AF self-management app and is 
also commonly reported as the most common self-management feature identified 
within health apps.20, 25, 27 This is because education, particularly tiered education43 
is considered a prerequisite to informed patient-centred care. Tailored education is a 
key recommendation within the 2016 European Society of Cardiology atrial fibrillation 
guidelines,12 and is known to significantly promote self-management in the older 
adult population, in particular medication adherence, but also other aspects of self-
care (e.g. dietary changes) by increasing competence and reducing anxiety.44, 45 
Despite this, education is not always a priority of mHealth apps. For example, in a 
review of systematic reviews of mHealth in chronic disease management, only eight 
interventions (n=30) identified education as an intervention modality compared with 
19 supporting a tracking function,46 indicating that mHealth apps emphasise 
observing behaviours over changing behaviours.47 A positive outcome from our 
review was the comprehensive educational content across all five apps.  
All five apps met the minimum MARS acceptable threshold score of three for the 
Information Quality dimension.37 It is unclear what type of interactive material is 
desirable to relay educational content to the target population.43 Apps included in this 
review lacked incorporated multimedia. Information was portrayed in unexciting text 
based formats, reflected in the average ‘poor’ MARS Subjective Quality dimension 
rating (MARS= 2.7). App design can greatly benefit from the input from end-users 
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(both existing and non-smartphone users) to improve aesthetic, content and 
engagement. However, to be an effective method for mHealth development the 
patient representative group must include a range of health literacy levels. The only 
app included within this review that reported involving patient representatives in the 
design stage (MyAF)48 was found to be heavily text dense. To avoid an app-based 
health promotion tool that widens the health inequality gap, care must be given to 
developing and testing the app with participants with a range of health literacy 
levels.49 
Health related app data management has frequently been reported to be no more 
secure than non-health related apps.20, 50 As many as two-thirds of mHealth apps 
function without accessible privacy statements,21, 27, 51, 52 leaving user’s privacy and 
data security at risk. A lack of clarity and transparency in policy has previously been 
reported51 and encouragingly this study obtained 100% of privacy statements for the 
included AF self-management apps. However, the high level of literacy required to 
understand privacy statements impedes the person’s ability to scrutinise app integrity 
for themselves. Subsequently, a user’s consent to download and use the app could 
be considered uninformed consent and therefore ethically dubious.21, 50, 51 Since the 
mHealth apps’ core functions rely on the use and storage of personally identifiable 
information (4/5 apps), substantial improvements are required to ensure future 
comprehensive and transparent data security principles.  
No app included within this review claimed that functions were aligned with 
behaviour change techniques (BCTs). Although it is recognised that self-
management effectiveness would be improved if supported by integrated BCTs,17, 35, 
43 we found the number of identifiable BCTs within the evaluated AF apps were low. 
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This is a common finding in other chronic disease self-management apps. For 
example, in a study analysing 44 French mHealth chronic disease self-management 
apps as few as 0-5 BCTs were identified.47 Similarly, within 40 diabetes apps, a 
mean of only 4.4 BCTs out of a possible 26 were classifiable.28 A surprising finding 
within this review was the lack of goal setting functions in any app analysed. Goal 
setting is considered integral to digital interventions, coupled with tailored feedback 
to provide motivation, accountability and guidance to achieve desired health 
outcomes.53 An example goal in AF self-management would be time in 
anticoagulation therapeutic range, achieved through medication adherence. The 
absence of such an integral BCT negatively affects an app’s ability to help users 
achieve long-lasting lifestyle changes. The lack of BCTs found within the apps 
analysed could be a result of omitting behaviour-change specialist input during early 
app development stages. mHealth apps are also consistently developed without 
clinical input. One study investigating over 650 self-management apps found as little 
as 12.3% of apps benefitted from healthcare professional involvement.54 Although 
50% of apps included within this review stated the involvement of healthcare 
professionals, no app underwent evaluation in a clinical trial, a finding consistent with 
other health app reviews,20, 25 therefore regardless of the presence or absence of 
BCTs, effectiveness was not evaluated or demonstrated.  
As scored by MARS, functionality and information quality were rated positively.37 
However, engagement and subjective quality dimensions failed to score >3, 
indicative that apps would fail to retain user interaction.55 The strongly positive 
correlation between engagement and aesthetics MARS quality scores suggests that 
untargeted, cumbersome and unintuitive design would be linked with low uptake.56 
Interrater reliabilities were used within this study to gauge whether the MARS scale 
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would provide objective measurement of an otherwise subjective domain. Despite 
interrater reliability across all MARS subscales performing comparably, if not better, 
than the original authors (2-way mixed ICC= 0.82)39 an aesthetics domain ICC of 
0.26 is suggestive that the MARS tool was not able to negate subjectivity bias within 
this category.  
Strengths and Limitations 
To our knowledge this is the first review to analyse and synthesise the content of 
apps that help support self-management of AF. Although this study employed an 
extensive search strategy with no restriction placed on the number of apps scanned, 
it is still recognised that the speed of software development means there is always 
the potential for new apps to reach the market and thus not be included in this 
review. Search terminology presented two limitations to this study. Firstly, just two 
search terms were utilised, this was due to the large number of duplicated identified 
apps across the two searches. Secondly, app store search algorithm sensitivity 
varied greatly across the two stores, and it is acknowledged that this could have 
resulted in the accidental omission of apps. The method used to gather information 
on whether apps had undergone clinical trial could be further improved by performing 
a bibliometric database search. However, as it is often common practice for 
developers to state clinical trial information within app store descriptions as an 
advertisement for the authenticity and effectiveness of the app to potential end 
users, we considered that for the purpose of this study, app description review was 
sufficient. 
It is recognised that the most important stakeholders are people living with AF. In this 
scoping review, assessments of usability were completed by professionals. Future 
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studies would benefit from asking end users, alongside researchers to undertake a 
concurrent MARS assessment. Comparable interrater reliabilities between the two 
groups would be a good indication whether the scale is capable of overcoming any 
potential reviewer bias introduced through prior knowledge of digital health and 
behaviour change theory. Due to the low number of apps meeting the inclusion 
criteria, the authors recognise the weak generalisability of this review to other 
mHealth apps. However, the results reflect the current state of play regarding the 
small number of available apps targeted towards AF.  
Conclusion 
This review reports a lack of commercially available AF self-management apps that 
are of sufficient standard for use in healthcare settings. This review highlights the 
need for a comprehensive, co-designed, clinically validated AF self-management 
app with deeper integration of BCTs, data security and transparency. 
Implications for Practice 
 In the future mHealth apps to improve self-management in patients with atrial 
fibrillation should be co-designed with end users and healthcare 
professionals. 
 Currently available atrial fibrillation self-management apps lack the required 
behaviour change techniques likely to affect beneficial long-lasting lifestyle 
changes.  
 To gain the trust of end users, there is a need to develop a clinically validated 
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Figures and Tables  




Table 1. App characteristics  













"An educational resource and tool for 
people with Atrial Fibrillation, that records 
symptoms and quality of life data that can 
be shared with the healthcare team before 
each hospital visit." 












"Combining a pill tracker, mood tracker 
and a health journal, this app puts all your 
medication needs in one place" 




"To help manage long term conditions, an 
app to support patients to manage their 
condition - Atrial Fibrillation" 





Afib Manager Apple 
"Getting the full picture with your Atrial 
Fibrillation-Afib Manager can help you 
manage the symptoms that affect you 
every day. Track your progress, manage 
your medications and treatments including 
reminders" 
Not Given 11/07/19 No Rating Commercial Unknown 
MyAF Apple  
"An educational resource and tool for 
people with Atrial Fibrillation, that records 
symptoms and quality of life data that can 
be shared with the healthcare team before 
each hospital visit." 







*Healthcare Professional Involvement: Where a healthcare professional was involved in the design and content of app development. This does not pertain to 




Table 2. App functions  



























































Education      
Text-based educational information  -    
Multimedia  - - - - - 
Links to external education  - - -  - 
Functioning multimedia/links - - - - - 
Self-monitoring      
Symptom/trigger diary   -   
Medication tracker -  -  - 
Health data input e.g. heart rate  - -   
Goal setting - - - - - 
App user interaction      
Reminders/alerts -  -  - 
Refill tracker -  - - - 
Encourage check in -  - - - 
Export data -  -  - 
Reward system - - -  - 
Patient medical information  
  
  
Stores medical information  - - -  
Calculates AF related health scores  - - -  
Stores lab results   - -  
Support network  




  -   
Community network - - -  - 
Friends/family support -  - - - 
 

















Basic notice/disclosure   
The privacy policy is easily discoverable 2 (66) 2 (100) 4 (80) 
The privacy policy is downloadable without downloading the app 2 (66) 2 (100) 4 (80) 
There is a short form notice (in plain English) highlighting key data practices 2 (66) 2 (100) 4 (80) 
The privacy statement is available in other languages 1 (33) 0 (0) 1 (20) 
Key compliance policies       
The privacy policy provides a summary of the data retention policy 2 (66) 2 (100) 4 (80) 
The privacy policy includes a specific timeframe/reason for data retention 1 (33) 1 (50) 2 (40) 
Protect privacy and define protected sharing       
The app collects personally identifiable information 2 (66) 2 (100) 4 (80) 
The app shares personally identifiable information with a 3rd party 0 (0) 0 (0) 0 (0) 
The app shares data with a 3rd party 2 (66) 2 (100) 4 (80) 
The app use 'cookies' 2 (66) 2 (100) 4 (80) 
Miscellaneous      
The policy states whether data encryption is used to enhance security 2 (66) 2 (100) 4 (80) 
The policy states compliance with General Data Protection Regulations 3 (100) 2 (100) 5 (100) 
 
Table 4. Assessment of behaviour change techniques  
Behaviour Change Techniques Google Apps Apple Apps 


























































Action planning  -  -  - 
Prompt/cues  -  -  - 
Self-monitoring  -  -  - 
Feedback on behaviour  -  -  - 
Monitoring of behaviour by others without feedback    -   
Social support (unspecified)  -  - - - 
Information about the antecedents  - - - - - 
Instruction on how to perform a behaviour  - - - - - 
Information about the health consequence   -  -  
Demonstration of the behaviour video  - - - - - 
Social comparison  - - - - - 
Behavioural practice/rehearsal  - - - - - 
As assessed by ABACUS36      
App knowledge and information       
Has the ability to customise and personalise some features -  - - - 
Was created with expertise and/or provides information 
consistent with national guidelines 
 -  -  
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Asks for baseline information   -   
Provides instruction on how to perform the behaviour  - - -  
Provides information about the consequences of continuing 
and/or discontinuing behaviour 
 - - -  
App goal and planning       
Asks for willingness for behaviour change - - - - - 
Allows for goal setting - - - - - 
Has the ability to review goals, update and change when 
necessary 
- - - - - 
App feedback and monitoring       
Gives the user the ability to understand the difference 
between current action and future goals 
-  -  - 
Has the ability to allow the user to easily self-monitor 
behaviour 
-  -  - 
Has the ability to share behaviours with others and/or allow 
for social comparison 
-  -  - 
Has the ability to give the user feedback -  -  - 
Has the ability to export data from the app - - -  - 
Provides a material or social reward or incentive - - - - - 
Provides general encouragement - - - - - 
App actions       
Has reminders and/or prompts or cues for activity -  - - - 
Encourages positive habit formation -  - - - 
Allows or encourages for practice or rehearsal, in addition to 
daily activities 
- - - - - 
Provides opportunities to plan for barriers - - - - - 
Assists with or suggests restructuring the physical or social 
environment 
- - - - - 
Assists with distraction or avoidance - - - - - 
 










































































MyAF (Android) 3.0 4.2 3.6 4.1 3.7 2.9 
Pill Reminder and Medication Tracker 2.9 3.6 2.9 3.7 3.3 2.7 
Manage Your Health 2.2 2.4 3.3 3.5 2.8 1.7 
Afib Manager 3.7 4.1 3.7 3.9 3.9 3.6 
MyAF (Apple) 3.0  4.2 3.6 4.1 3.7 2.9 
 
